Your browser doesn't support javascript.
loading
Medical treatment of early breast cancer.
Bjerre, Christina Annette; Rønlev, Jeanette Dupont; Knop, Ann Søegaard.
Afiliação
  • Bjerre CA; Afdeling for Kræftbehandling, Københavns Universitetshospital - Rigshospitalet.
  • Rønlev JD; Onkologisk Afdeling, Odense Universitetshospital.
  • Knop AS; Afdeling for Kræftbehandling, Københavns Universitetshospital - Rigshospitalet.
Ugeskr Laeger ; 186(12)2024 03 18.
Article em Da | MEDLINE | ID: mdl-38533871
ABSTRACT
Adjuvant and neoadjuvant therapy of early breast cancer reduces the risk of relapse and breast cancer mortality. Treatment modalities include chemotherapy, endocrine therapy, human epidermal growth factor receptor 2-targeted agents, bisphosphonates, immunotherapy, cyclin-dependent kinase inhibitors 4/6- and poly-ADP-ribose polymerase inhibitors. All cases are reviewed at multidisciplinary breast cancer tumour boards. An individualized risk stratification model is applied in this review to optimize the risk-benefit ratio for each patient, and shared decision-making is an integrated part of (neo)adjuvant therapy. Danish guidelines for breast cancer treatment are available at Danish Breast Cancer Cooperative Group's home page.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Antineoplásicos Limite: Female / Humans Idioma: Da Revista: Ugeskr Laeger Ano de publicação: 2024 Tipo de documento: Article País de publicação: Dinamarca

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Antineoplásicos Limite: Female / Humans Idioma: Da Revista: Ugeskr Laeger Ano de publicação: 2024 Tipo de documento: Article País de publicação: Dinamarca